Langerhans cell histiocytosis and etoposide: risks vs. benefits.
D'Angio
G J
GJ
D002648:Child; D005047:Etoposide / Q000009:adverse effects / Q000627:therapeutic use*; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000139:chemically induced; D012307:Risk Factors
D005047:Etoposide